Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,211
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,841
Class I recallsReasonable probability of serious health consequences
24,366
Class II recallsTemporary or medically reversible health consequences
2,892
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,073 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,714 recalls have been announced year to date.
  • Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (297).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2

Showing 18,101–18,120 of 18,578 recalls

FDA Recall Terminated Historical recordClass II

Medi-bolic Booster Injectable (methionine 8.3 mg/mL, choline chloride 16.6 mg/mL, inositol 16.6 mg/mL, cyanocobalamin USP [Vit B12] 0.33 mg/mL, chromium chloride 2.6 mg/mL), 30 mL multi-dose vials, Rx3 Compounding Pharmacy, 12230 Ironbridge Rd., Suite C, Chester, VA 23831.

by RX South LLC DBA RX3 Pharmacy

Reason
CGMP Deviations: Pharmaceutical for injection was not manufactured according to Good Manufacturing Procedures.
Published
March 20, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules, 15 mg, Rx Only, C II, 100 capsules per bottle, MFG. By Actavis Elizabeth LLC. 200 Elmora Ave, Elizabeth, NJ, 07207, USA, NDC 0228-3063-11.

by Actavis Elizabeth LLC

Reason
Failed Dissolution Specification: This product recall is due to the product lot # 50077231 exceeding dissolution specifications. All other test specifications were met.
Published
March 13, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Wal-Mart Equate Tussin CF Adult Maximum Strength, Multi-Symptom Cold, (dextromethorphan HBr 10 mg, guaifenesin 200 mg, phenylephrine HCI 5 mg), 8 FL OZ (235 mL) (NDC 49035-229-08; UPC Code: 6-81131-03884-30), Distributed by: Wal-Mart Stores, Inc., Bentonville, AR 72712.

by Aaron Industries Inc

Reason
Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles. If the product is shaken or warmed the white particles goes into the solution.
Published
March 13, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Select Brand Cough Control CF Max, Maximum Strength for MUCUS RELIEF, (dextromethorphan HBr 10 mg, guaifenesin 200 mg, phenylephrine HCI 5 mg), 4 fl.oz 12pk (NDC 15127-025-04; UPC Code: 0-15127-02535-5), Distributed by: Select Brand Distributors, Pine Bluff, AR 71603 USA.

by Aaron Industries Inc

Reason
Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles. If the product is shaken or warmed the white particles goes into the solution.
Published
March 13, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Rite Aid Maximum Strength Tussin Cough & Cold Mucus Relief CF, (dextromethorphan HBr 10 mg, guaifenesin 200 mg, phenylephrine HCI 5 mg, 4 FL. OZ./12 PK (UPC Code: 0-11822-57307-8) and 8 FL.OZ./12 PK (UPC Code: 0-11822-57313-9), Distributed by: Rite Aid, Camp Hill, PA, 17011

by Aaron Industries Inc

Reason
Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles. If the product is shaken or warmed the white particles goes into the solution.
Published
March 13, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Well at Walgreens Wal-Tussin CF Max, MAXIMUM STRENGTH ADULT NON-DROWSY, Multi-Symptom Cold, (dextromethorphan HBr 10 mg, guaifenesin 200 mg, phenylephrine HCI 5 mg), 8 FL OZ (237 mL) bottles, Distributed by: Walgreen Co, Deerfield, IL 60015 ---- NDC 0363-0229-08

by Aaron Industries Inc

Reason
Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles. If the product is shaken or warmed the white particles goes into the solution.
Published
March 13, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045, NDC 0409-1555-54

by Hospira Inc.

Reason
Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.
Published
March 13, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

0.9% Sodium Chloride Injection USP, 100 mL Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7984-23,

by Hospira Inc.

Reason
Lack of Assurance of Sterility: There is the potential for solution to leak from the administrative port to the fill tube seal.
Published
March 13, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Montelukast Sodium Tablets, 10 mg (base), packaged in a) 30-count tablets per bottle (NDC 68462-392-30) and b) 90-count tablets per bottle (NDC 68462-392-90), Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430.

by Glenmark Generics Inc., USA

Reason
Chemical Contamination: The recall has been initiated based on multiple complaints received from pharmacists and consumers reporting that they detected an off-odor, described as moldy, musty or fishy in nature which has been identified as trace levels of Tribromoanisole (TBA) and Trichloroanisole (TCA).
Published
March 13, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Citalopram tablets USP, 40mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-344-30

by Dr. Reddy's Laboratories, Inc.

Reason
Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Published
March 6, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-343-30

by Dr. Reddy's Laboratories, Inc.

Reason
Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Published
March 6, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Citalopram tablets USP, 10mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-342-30

by Dr. Reddy's Laboratories, Inc.

Reason
Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Published
March 6, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Bronkaid Dual Action Formula, Ephedrine Sulfate 25 mg/Bronchodilator, Guaifenesin 400 mg/Expectorant, a) 24 coated caplets per blister pack, UPC 300240537879, b) 60 coated caplets per blister pack, UPC 300240537855, Bayer HealthCare LLC, Consumer Care, P.O. Box 1910, Morristown, NJ, 07962.

by Bayer Healthcare, LLC

Reason
Labeling: Label lacks warning or Rx legend; Certain information was inadvertently excluded from the product carton label.
Published
March 6, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

0.9% Sodium Chloride Irrigation, USP, 3000 mL, Sterile, Non pyrogenic, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7972-08

by Hospira Inc.

Reason
Lack of Assurance of Sterility: There is a potential for the solution to leak from the administration port of the primary container.
Published
March 6, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217

by Actavis Pharmaceuticals

Reason
Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.
Published
March 6, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-329-09

by Amedra Pharmaceuticals LLC

Reason
Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.
Published
March 6, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-328-09

by Amedra Pharmaceuticals LLC

Reason
Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.
Published
March 6, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-327-09

by Amedra Pharmaceuticals LLC

Reason
Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.
Published
March 6, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Belladonna Alkaloids (hyoscyamine sulfate, USP 0.1037 mg; atropine sulfate, USP 0.0194 mg; scopolamine HBr, USP 0.0065 mg) with Phenobarbital (USP 16.2 mg) Tablets, packaged in a) 1000-count tablets per bottle (NDC 0143-1140-10; b) 5000-count tablets per bottle (NDC 143-1140-51); Rx only, Manufactured by: West-ward Pharmaceutical Corp. Eatontown, NJ 07724

by West-Ward Pharmaceutical Corp.

Reason
Presence of Foreign Substance: Uncharacteristic blacks spots were found in tablets.
Published
March 6, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDC 0409-6102-04

by Hospira, Inc.

Reason
Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial
Published
March 6, 2013
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.